XML 12 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segments (Tables)
 9 Months Ended
Sep. 30, 2013
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
Revenues and operating income (loss) by segment are as follows (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2013
 
2012
 
2013
 
2012
Revenues:
 
 
 
 
 
 
 
Sequenom Laboratories
$
33,268

 
$
12,501

 
$
86,877

 
$
25,391

Sequenom Bioscience
10,683

 
10,352

 
30,423

 
30,634

Total revenues
$
43,951

 
$
22,853

 
$
117,300

 
$
56,025

 
 
 
 
 
 
 
 
Operating income (loss):
 
 
 
 
 
 
 
Sequenom Laboratories
$
(9,552
)
 
$
(19,694
)
 
$
(40,562
)
 
$
(54,379
)
Sequenom Bioscience
1,445

 
843

 
2,527

 
1,595

Unallocated
(17,948
)
 
(10,810
)
 
(43,722
)
 
(30,304
)
Total loss from operations
$
(26,055
)
 
$
(29,661
)
 
$
(81,757
)
 
$
(83,088
)